首页 | 本学科首页   官方微博 | 高级检索  
     


Signaling Dependent and Independent Mechanisms in Pemphigus Vulgaris Blister Formation
Authors:Masataka Saito   Sara N. Stahley   Christopher Y. Caughman   Xuming Mao   Dana K. Tucker   Aimee S. Payne   Masayuki Amagai   Andrew P. Kowalczyk
Affiliation:1Departments of Cell Biology, Dermatology and the Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America;2Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America;3Department of Dermatology, Keio University, Tokyo, Japan;NCMLS, Radboud University Nijmegen Medical Center, The Netherlands
Abstract:Pemphigus vulgaris (PV) is an autoimmune epidermal blistering disease caused by autoantibodies directed against the desmosomal cadherin desmoglein-3 (Dsg3). Significant advances in our understanding of pemphigus pathomechanisms have been derived from the generation of pathogenic monoclonal Dsg3 antibodies. However, conflicting models for pemphigus pathogenicity have arisen from studies using either polyclonal PV patient IgG or monoclonal Dsg3 antibodies. In the present study, the pathogenic mechanisms of polyclonal PV IgG and monoclonal Dsg3 antibodies were directly compared. Polyclonal PV IgG cause extensive clustering and endocytosis of keratinocyte cell surface Dsg3, whereas pathogenic mouse monoclonal antibodies compromise cell-cell adhesion strength without causing these alterations in Dsg3 trafficking. Furthermore, tyrosine kinase or p38 MAPK inhibition prevents loss of keratinocyte adhesion in response to polyclonal PV IgG. In contrast, disruption of adhesion by pathogenic monoclonal antibodies is not prevented by these inhibitors either in vitro or in human skin explants. Our results reveal that the pathogenic activity of polyclonal PV IgG can be attributed to p38 MAPK-dependent clustering and endocytosis of Dsg3, whereas pathogenic monoclonal Dsg3 antibodies can function independently of this pathway. These findings have important implications for understanding pemphigus pathophysiology, and for the design of pemphigus model systems and therapeutic interventions.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号